Edition:
United States

Mersana Therapeutics Inc (MRSN.OQ)

MRSN.OQ on NASDAQ Stock Exchange Global Select Market

8.02USD
19 Oct 2018
Change (% chg)

$-0.29 (-3.49%)
Prev Close
$8.31
Open
$8.34
Day's High
$8.71
Day's Low
$8.01
Volume
15,166
Avg. Vol
50,058
52-wk High
$23.67
52-wk Low
$7.79

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 4.19 -0.538
Mar '18 3.06 -0.544
FY 2017 Dec '17 3.26 -0.613
Sep '17 6.27 -0.340
Jun '17 3.73 -0.394
Mar '17 4.29 -0.356
FY 2016 Dec '16 12.00 0.056
Sep '16 3.26 -0.258
Jun '16 6.22 -0.166
Mar '16 3.70 -0.237
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 4.48 6.50 3.00 7.50
Quarter Ending Mar-19 2 4.85 5.50 4.20 --
Year Ending Dec-18 6 15.77 18.30 13.00 22.22
Year Ending Dec-19 6 20.79 27.00 16.76 30.47
Earnings (per share)
Quarter Ending Dec-18 6 -0.62 -0.51 -0.73 -0.32
Quarter Ending Mar-19 2 -0.55 -0.51 -0.59 --
Year Ending Dec-18 6 -2.30 -2.07 -2.43 -2.11
Year Ending Dec-19 6 -2.31 -2.05 -2.55 -1.92
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta -- 0.63 0.87
Price to Sales (TTM) 12.39 109.82 6.55
Price to Book (MRQ) 4.54 13.72 4.00
Price to Tangible Book (MRQ) 4.55 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 12.45 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago -27.89 91.25 6.56
Sales - 5 Yr. Growth Rate -- 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago -36.57 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago -113.65 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 3.21 5.52 2.99
LT Debt to Equity (MRQ) 0.00 15.33 11.31
Total Debt to Equity (MRQ) 0.00 18.80 14.15
Interest Coverage (TTM) -- -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -278.92 -- --
EBITD - 5 Yr. Avg -- -164.07 16.13
Operating Margin (TTM) -285.21 -618.88 3.36
Operating Margin - 5 Yr. Avg. -- -178.92 11.28
Pre-Tax Margin (TTM) -276.80 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -- -181.48 11.54
Net Profit Margin (TTM) -276.80 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -- -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 215,167 24,741,437 725,680,242
Net Income/Employee (TTM) -595,590 1,102,410 84,001,075
Receivable Turnover (TTM) 15.30 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.17 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.36 0.35 9.83
Return on Assets - 5 Yr. Avg. -- 3.11 10.94
Return on Investment (TTM) -72.12 1.96 12.83
Return on Investment - 5 Yr. Avg. -- 2.91 14.05
Return on Equity (TTM) -- 1.12 14.95
Return on Equity - 5 Yr. Avg. -- -0.97 15.39
  1 Year 3 Year 5 Year
Sales % -30.30 -- --
EPS (TTM) % -181.05 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Mersana Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -36.36 -36.52 5 59
13 Week -50.33 -52.06 8 76
26 Week -44.05 -49.31 14 56
52 Week -52.55 -58.06 20 83
YTD -45.34 -49.34 20 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.94%
# of Holders: 86
Total Shares Held: 19,203,091
3 Mo. Net Change: 961
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 3
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.